These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7081970)

  • 1. Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.
    McLafferty MA; Koch RL; Goldman P
    Antimicrob Agents Chemother; 1982 Jan; 21(1):131-4. PubMed ID: 7081970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between metronidazole metabolism and bactericidal activity.
    Chrystal EJ; Koch RL; McLafferty MA; Goldman P
    Antimicrob Agents Chemother; 1980 Oct; 18(4):566-73. PubMed ID: 6255861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and properties of metronidazole-resistant mutants of Bacteroides fragilis.
    Britz ML; Wilkinson RG
    Antimicrob Agents Chemother; 1979 Jul; 16(1):19-27. PubMed ID: 475371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the bactericidal activity of clindamycin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1991; 14(5):377-82. PubMed ID: 1797454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate dehydrogenase activity as a cause of metronidazole resistance in Bacteroides fragilis NCTC 11295.
    Narikawa S; Suzuki T; Yamamoto M; Nakamura M
    J Antimicrob Chemother; 1991 Jul; 28(1):47-53. PubMed ID: 1769942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Bacteroides fragilis resistance to metronidazole.
    Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
    Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of the two principal oxidative metabolites of metronidazole against Bacteroides fragilis and related species.
    Haller I
    Antimicrob Agents Chemother; 1982 Jul; 22(1):165-6. PubMed ID: 7125628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
    Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
    Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal antimicrobial synergism between Escherichia coli and Bacteroides fragilis in the presence of metronidazole.
    Soriano F; Ponte MC; Gaspar MC
    J Clin Pathol; 1982 Oct; 35(10):1150-2. PubMed ID: 6752209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of an amino reduction product of metronidazole in bacterial cultures: lack of bactericidal activity.
    Ehlhardt WJ; Beaulieu BB; Goldman P
    Biochem Pharmacol; 1987 Jan; 36(2):259-64. PubMed ID: 3545214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate dehydrogenase activity and metronidazole susceptibility in Bacteroides fragilis.
    Tabaqchali S; Pantosti A; Oldfield S
    J Antimicrob Chemother; 1983 May; 11(5):393-400. PubMed ID: 6874627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
    Dijkmans BA; Mattie H; Hermans J; van Furth R
    J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.
    Ibrahim KH; Gunderson BW; Hermsen ED; Hovde LB; Rotschafer JC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4195-9. PubMed ID: 15504841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriological and clinical studies on metronidazole in Bacteroides fragilis infections (author's transl)].
    Shimada K; Inamatsu T; Sato K
    Jpn J Antibiot; 1979 Feb; 32(2):191-4. PubMed ID: 439390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of Bacteroides fragilis plasmid genes affecting metronidazole resistance and ultraviolet survival in Escherichia coli.
    Wehnert GU; Abratt VR; Goodman HJ; Woods DR
    Plasmid; 1990 Mar; 23(2):155-8. PubMed ID: 2194230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.
    Betriu C; Cabronero C; Gomez M; Picazo JJ
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):352-6. PubMed ID: 1396757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metronidazole-resistant Bacteroides fragilis wound infection.
    O'Donoghue MA; Potter J; Allen KD
    J Infect; 1992 Sep; 25(2):211-4. PubMed ID: 1431176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of metronidazole on Bacteroides fragilis and/or Escherichia coli in vitro and in vivo.
    Rylander M; Holm SE; Brorson JE; Johnsson J; Norrby R
    J Antimicrob Chemother; 1981 Mar; 7(3):257-67. PubMed ID: 7024242
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced pathogenicity of susceptible strains of the Bacteroides fragilis group subjected to low doses of metronidazole.
    Diniz CG; Arantes RM; Cara DC; Lima FL; Nicoli JR; Carvalho MA; Farias LM
    Microbes Infect; 2003 Jan; 5(1):19-26. PubMed ID: 12593969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.